Minoryx Press Release
2021-04-12

Minoryx Phase 2/3 ‘ADVANCE’ study results to be presented at the 2021 American Neurological Association (AAN) Annual Meeting

Minoryx Phase 2/3 ‘ADVANCE’ study…
read more
Immunic Press Release
2021-04-01

Immunic and 4SC AG Sign Agreement Regarding the Settlement of Royalty Obligations for Immunic’s Lead Program, IMU-838

Immunic and 4SC AG Sign…
read more
eTheRNA Press Release
2021-03-22

Consortium led by eTheRNA immunotherapies Awarded EU Commission TIGER Grant of EUR 6.9 million

Consortium led by eTheRNA immunotherapies…
read more
Indigo Press Release
2021-03-18

Indigo Diabetes Initiates First Clinical Study of its Continuous Glucose Monitoring Sensor

Indigo Diabetes Initiates First Clinical…
read more
Exevir Press Release
2021-03-16

ExeVir Announces Close of US$50 million / EUR42 million Series A Financing

ExeVir Announces Close of US$50…
read more
Exevir Press Release
2021-03-09

ExeVir Bio Announces New Publication from VIB Scientists Showing Potent and Broad Neutralizing Activity and Infection Protection Against SARS-COV, its Variants of Concern and Related Coronaviruses

ExeVir Bio Announces New Publication…
read more
eTheRNA Press Release
2021-03-05

ConserV Bioscience and eTheRNA immunotherapies to Collaborate on Development of mRNA Vaccines for Infectious Diseases

ConserV Bioscience and eTheRNA immunotherapies…
read more
ONA Press Release
2021-03-05

ONA Therapeutics appoints Mark Throsby to its Board of Directors

ONA Therapeutics appoints Mark Throsby…
read more
Immunic Press Release
2021-02-18

Immunic, Inc. Announces Positive Top-Line Data From Investigator- Sponsored Phase 2 Proof-of-Concept Clinical Trial of IMU-838 in Primary Sclerosing Cholangitis

Immunic, Inc. Announces Positive Top-Line…
read more
Immunic Press Release
2021-02-18

Immunic, Inc. Announces That Oral Treatment IMU-838 Shows Evidence of Clinical Activity in Moderate COVID-19 in Phase 2 CALVID-1 Trial

Immunic, Inc. Announces That Oral…
read more